tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AYTU Stock Latest News

Aytu BioPharma management to meet with Maxim
The FlyAytu BioPharma management to meet with Maxim
2M ago
AYTU
Aytu, Hasbro, Hyatt, Gen Digital, Carrier: Trending by Analysts
PremiumWeekend Updates
Aytu, Hasbro, Hyatt, Gen Digital, Carrier: Trending by Analysts
2M ago
H
GEN
Aytu BioPharma initiated with a Buy at Lake Street
PremiumThe Fly
Aytu BioPharma initiated with a Buy at Lake Street
2M ago
AYTU
Aytu BioPharma initiated with a Buy at Ascendiant
PremiumThe Fly
Aytu BioPharma initiated with a Buy at Ascendiant
2M ago
AYTU
Aytu BioPharma appoints Gerwin Westfield as SVP, scientific affairs
PremiumThe Fly
Aytu BioPharma appoints Gerwin Westfield as SVP, scientific affairs
2M ago
AYTU
Aytu BioScience Expands Lending Agreement for EXXUA Launch
PremiumCompany AnnouncementsAytu BioScience Expands Lending Agreement for EXXUA Launch
2M ago
8K
AYTU
Aytu BioPharma expands, extends lending agreement with Eclipse
Premium
The Fly
Aytu BioPharma expands, extends lending agreement with Eclipse
2M ago
AYTU
Aytu BioPharma’s Strategic Acquisition of EXXUA Drives Buy Rating and Raises Price Target
Premium
Ratings
Aytu BioPharma’s Strategic Acquisition of EXXUA Drives Buy Rating and Raises Price Target
3M ago
AYTU
Aytu BioPharma Closes $16.6M Stock Offering for EXXUA
PremiumCompany Announcements
Aytu BioPharma Closes $16.6M Stock Offering for EXXUA
3M ago
8K
AYTU
Aytu BioScience Signs Exclusive Agreement for EXXUA
PremiumCompany Announcements
Aytu BioScience Signs Exclusive Agreement for EXXUA
3M ago
8K
AYTU
Aytu BioPharma Announces $12.9M Public Offering
PremiumCompany Announcements
Aytu BioPharma Announces $12.9M Public Offering
3M ago
8K
AYTU
Aytu BioPharma 9.6M share Secondary priced at $1.50
PremiumThe Fly
Aytu BioPharma 9.6M share Secondary priced at $1.50
3M ago
AYTU
Aytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals
PremiumThe FlyAytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals
3M ago
AYTU
Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering
Premium
The Fly
Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering
3M ago
AYTU
Aytu BioPharma announces exclusive commercialization agreement for Exxua
Premium
The Fly
Aytu BioPharma announces exclusive commercialization agreement for Exxua
3M ago
AYTU
Aytu BioPharma files to sell 6.74M shares of common stock
PremiumThe Fly
Aytu BioPharma files to sell 6.74M shares of common stock
3M ago
AYTU
Aytu BioScience Holds 2025 Annual Meeting
PremiumCompany Announcements
Aytu BioScience Holds 2025 Annual Meeting
4M ago
8K
AYTU
Aytu BioScience: Strong Financial Performance and Strategic Growth Opportunities Drive Buy Rating
PremiumRatings
Aytu BioScience: Strong Financial Performance and Strategic Growth Opportunities Drive Buy Rating
4M ago
AYTU
Aytu BioScience Reports Strong Earnings and Strategic Success
PremiumCompany Announcements
Aytu BioScience Reports Strong Earnings and Strategic Success
4M ago
AYTU
Aytu BioPharma Reports Strong Q3 2025 Earnings
PremiumCompany AnnouncementsAytu BioPharma Reports Strong Q3 2025 Earnings
4M ago
AYTU
Aytu BioPharma’s treatment of Marfan syndrome receives FDA orphan designation
Premium
The Fly
Aytu BioPharma’s treatment of Marfan syndrome receives FDA orphan designation
5M ago
AYTU
Evoke Pharma appoints Greg Pyszczymuka to board of directors
Premium
The Fly
Evoke Pharma appoints Greg Pyszczymuka to board of directors
6M ago
AYTU
EVOK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >